HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
OTOA
otoancorin
Chromosome 16 Β· 16p12.2|16p12.2
NCBI Gene: 146183Ensembl: ENSG00000155719.18HGNC: HGNC:16378UniProt: Q05BM7
18PubMed Papers
21Diseases
0Drugs
89Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
cell surfacecell-matrix adhesionextracellular regionplasma membranehearing loss, autosomal recessivedeafnessRare genetic deafnessNon-syndromic genetic deafness
✦AI Summary

OTOA encodes otoancorin, a glycosylphosphatidylinositol (GPI)-anchored protein essential for inner ear development and hearing function 1. The protein is required for proper development of the tectorial membrane in the inner ear and may function as an adhesion molecule 1. Experimental studies confirm that OTOA is GPI-anchored to cell surfaces, with sequences downstream from amino acid 589 being critical for proper GPI anchorage 1. Mutations in OTOA cause autosomal recessive nonsyndromic hearing loss (DFNB22), which exhibits a characteristic mid-frequency hearing loss pattern 2. The hearing loss associated with OTOA mutations is progressive, with losses exceeding 10 dB per decade 3. OTOA variants are found with significant frequency in populations, with allelic frequencies of 0.61-0.69% reported in Brazilian and other cohorts 4. Both single nucleotide variants and copy number variations (deletions) in OTOA cause hearing loss, with CNVs representing the second most frequent cause among identified variants in Japanese hearing loss patients 2. The gene accounts for a notable proportion of autosomal recessive hearing loss cases, with diagnostic yields ranging from 0.3% in Japanese populations to higher frequencies in other ethnic groups 25.

Sources cited
1
OTOA encodes a GPI-anchored protein required for tectorial membrane development, with sequences downstream from amino acid 589 critical for GPI anchorage
PMID: 30740825
2
OTOA-associated hearing loss exhibits characteristic mid-frequency pattern and represents 0.3% of autosomal recessive hearing loss in Japanese patients
PMID: 31527525
3
OTOA mutations cause progressive hearing loss with losses exceeding 10 dB per decade
PMID: 36633841
4
OTOA variants have significant population frequency with allelic frequency of 0.61-0.69%
PMID: 36147510
5
Both SNVs and CNVs in OTOA cause hearing loss, contributing to autosomal recessive nonsyndromic hearing loss diagnosis
PMID: 27068579
Disease Associationsβ“˜21
hearing loss, autosomal recessiveOpen Targets
0.72Strong
deafnessOpen Targets
0.53Moderate
Rare genetic deafnessOpen Targets
0.52Moderate
Non-syndromic genetic deafnessOpen Targets
0.38Weak
hearing lossOpen Targets
0.37Weak
nonsyndromic genetic hearing lossOpen Targets
0.37Weak
autosomal recessive nonsyndromic hearing loss 7Open Targets
0.29Weak
major depressive disorderOpen Targets
0.23Weak
dysthymic disorderOpen Targets
0.21Weak
genetic disorderOpen Targets
0.19Weak
Hearing impairmentOpen Targets
0.17Weak
mood disorderOpen Targets
0.16Weak
depressive disorderOpen Targets
0.14Weak
schizophreniaOpen Targets
0.11Weak
autosomal dominant nonsyndromic hearing lossOpen Targets
0.09Suggestive
parasitic infectionOpen Targets
0.07Suggestive
nervous system diseaseOpen Targets
0.07Suggestive
anxiety disorderOpen Targets
0.06Suggestive
hearing loss, autosomal dominant 85Open Targets
0.06Suggestive
hearing loss, autosomal dominant 87Open Targets
0.06Suggestive
Deafness, autosomal recessive, 22UniProt
Pathogenic Variants89
NM_144672.4(OTOA):c.1880+1G>APathogenic
Rare genetic deafness|not provided|OTOA-related disorder|Autosomal recessive nonsyndromic hearing loss 22
β˜…β˜…β˜†β˜†2026
NM_144672.4(OTOA):c.746_751delinsA (p.Ser249fs)Pathogenic
Rare genetic deafness|not provided|Monogenic hearing loss
β˜…β˜…β˜†β˜†2025β†’ Residue 249
NM_144672.4(OTOA):c.335del (p.Lys112fs)Pathogenic
not provided|Monogenic hearing loss
β˜…β˜…β˜†β˜†2025β†’ Residue 112
NM_144672.4(OTOA):c.828del (p.Ser277fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 22|Rare genetic deafness|OTOA-related disorder|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 277
NM_144672.4(OTOA):c.399+2T>CPathogenic
not provided|OTOA-related disorder|Autosomal recessive nonsyndromic hearing loss 22|Sarcoma
β˜…β˜…β˜†β˜†2025
NM_144672.4(OTOA):c.92-1G>TPathogenic
not provided|OTOA-related disorder
β˜…β˜…β˜†β˜†2025
NM_144672.4(OTOA):c.2102del (p.Ile701fs)Pathogenic
not provided|OTOA-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 701
NM_144672.4(OTOA):c.806C>A (p.Ser269Ter)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 22|Rare genetic deafness
β˜…β˜…β˜†β˜†2024β†’ Residue 269
NM_144672.4(OTOA):c.1765del (p.Gln589fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 22|Rare genetic deafness|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 589
NM_144672.4(OTOA):c.562_569dup (p.Phe191fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 22|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 191
NM_144672.4(OTOA):c.1320+2T>CPathogenic
Autosomal recessive nonsyndromic hearing loss 22|not provided
β˜…β˜…β˜†β˜†2023
NM_144672.4(OTOA):c.1633_1634del (p.Leu545fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 22|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 545
NM_144672.4(OTOA):c.755G>A (p.Trp252Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 252
NM_144672.4(OTOA):c.2352del (p.Thr785fs)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 22
β˜…β˜…β˜†β˜†2022β†’ Residue 785
NM_144672.4(OTOA):c.1630-2A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2026
NM_144672.4(OTOA):c.1790del (p.Leu597fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2026β†’ Residue 597
NM_144672.4(OTOA):c.436C>T (p.Arg146Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 146
NM_144672.4(OTOA):c.1025A>T (p.Asp342Val)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 22|Autosomal recessive nonsyndromic hearing loss 1A
β˜…β˜†β˜†β˜†2025β†’ Residue 342
NM_144672.4(OTOA):c.3142G>T (p.Glu1048Ter)Pathogenic
Autosomal recessive nonsyndromic hearing loss 22
β˜…β˜†β˜†β˜†2025β†’ Residue 1048
NM_144672.4(OTOA):c.2035del (p.Glu679fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 679
View on ClinVar β†—
Related Genes
SNED1Shared pathway100%EPDR1Shared pathway100%TECTBProtein interaction96%OTOGProtein interaction96%TECTAProtein interaction77%THBS3Shared pathway50%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
21%
Brain
19%
Liver
18%
Ovary
13%
Heart
4%
Gene Interaction Network
Click a node to explore
OTOASNED1EPDR1TECTBOTOGTECTATHBS3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q05BM7
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.82LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.67 [0.55–0.82]
RankingsWhere OTOA stands among ~20K protein-coding genes
  • #14,765of 20,598
    Most Researched18
  • #853of 5,498
    Most Pathogenic Variants89 Β· top quartile
  • #6,974of 17,882
    Most Constrained (LOEUF)0.82
Genes detectedOTOA
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Association of Genetic Diagnoses for Childhood-Onset Hearing Loss With Cochlear Implant Outcomes.
PMID: 36633841
JAMA Otolaryngol Head Neck Surg Β· 2023
1.00
2
Genomic study of nonsyndromic hearing loss in unaffected individuals: Frequency of pathogenic and likely pathogenic variants in a Brazilian cohort of 2,097 genomes.
PMID: 36147510
Front Genet Β· 2022
0.90
3
The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands.
PMID: 28000701
Eur J Hum Genet Β· 2017
0.80
4
Clarification of glycosylphosphatidylinositol anchorage of OTOANCORIN and human OTOA variants associated with deafness.
PMID: 30740825
Hum Mutat Β· 2019
0.70
5
DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System.
PMID: 27068579
Hum Mutat Β· 2016
0.60